# Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer

> **NCT00247416** · PHASE2 · COMPLETED · sponsor: **Susanne Arnold** · enrollment: 60 (actual)

## Conditions studied

- Stage IV Non-small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Gemcitabine
- **DRUG:** Dexamethasone
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT00247416
- **Lead sponsor:** Susanne Arnold
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247416, "Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT00247416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*